The global Biosimulation Market was valued at USD 2.4 billion in 2023 and is projected to reach USD 8.4 billion by 2031, growing at a compound annual growth rate (CAGR) of 17.0% over the forecast period from 2024 to 2031. The increasing need for efficient drug discovery processes and the development of predictive modeling techniques are expected to drive...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian